29 November 2021 : Clinical Research
Combined Use of Transjugular Intrahepatic Portosystemic Shunt and Transarterial Chemoembolization in the Treatment of Esophageal and Gastric Variceal Bleeding: A Retrospective Study of 80 Patients with Hepatocellular Carcinoma and Portal Hypertension
Xinhua Zou1AB, Miao Xue1BCDE, Jiaping Li1EFG*DOI: 10.12659/MSM.934436
Med Sci Monit 2021; 27:e934436
Table 4 The survival analysis based on relative reasons of death between groups.
| Reasons of death | TIPS+TACE (n=42) | Endoscopy+TACE (n=38) |
|---|---|---|
| Liver failure | 19 (45.24%) | 17 (44.74%) |
| Gastrointestinal rebleeding | 1 (2.38%) | 4 (10.53%) |
| Hepatic encephalopathy | 2 (4.76%) | 3 (7.89%) |
| Multiple organ failure | 1 (2.38%) | 0 (0.00%) |
| Uncontrollable infection | 2 (4.76%) | 2 (5.26%) |
| Uncontrollable intrahepatic tumor progression | 10 (23.81%) | 8 (21.05%) |
| Uncontrolled progression of extrahepatic metastases | 7 (16.67%) | 4 (10.53%) |
| TIPS – transjugular intrahepatic portosystemic shunt; TACE – transarterial chemoembolization. Results reported as N (%) unless otherwise indicated. | ||